Influenza Diagnostics Market by (Product, Test, Specimen, and End User) – Size, Trends and Forecast 2024-2029
The global influenza diagnostics market is set to witness a growth rate of 5-8% in the next 5 years. Increasing incidence of influenza; government initiatives and awareness campaigns; technological advancements in diagnostics; globally rising healthcare expenditure; growing demand for rapid disease diagnosis; and rising geriatric population are some of the key factors driving the influenza diagnostics market. To learn more about the research report, download a sample report.
Influenza diagnostics refer to the tools and techniques used to detect and identify the influenza virus in patients. These diagnostics are essential for early and accurate detection, allowing timely treatment and preventing the spread of the virus. Common methods include rapid antigen tests, reverse transcription-polymerase chain reaction (RT-PCR), viral culture, and immunofluorescence assays. Rapid diagnostic tests (RDTs) are often used in point-of-care settings for quick results, while RT-PCR is considered the gold standard due to its high sensitivity and specificity. Accurate diagnostics are crucial for distinguishing influenza from other respiratory illnesses, guiding appropriate medical interventions.
To learn more about this report, download the PDF brochure
Increasing incidence of influenza to propel market demand
According to WHO, there are around a billion cases of seasonal influenza annually, including 3–5 million cases of severe illness. Influenza causes 290,000 to 650,000 respiratory deaths annually. The increasing incidence of influenza is driving the demand for influenza diagnostics as rising infection rates heighten the need for timely and accurate detection. Seasonal flu outbreaks, pandemic threats, and the emergence of new influenza strains amplify the pressure on healthcare systems to diagnose and manage cases effectively. Early diagnosis is crucial for controlling the spread of the virus and initiating appropriate antiviral treatments. As a result, healthcare providers are adopting advanced diagnostic tools like rapid antigen tests and RT-PCR, which offer quick and precise detection, fueling market growth for influenza diagnostics to meet the growing public health demand.
Government initiatives and awareness campaigns driving the market growth
Government initiatives and awareness campaigns are driving the market for influenza diagnostics by promoting early detection, vaccination, and public health preparedness. Various government bodies across the globe implement flu vaccination programs and conduct awareness campaigns to educate the public about the importance of timely diagnosis and treatment. These efforts encourage both healthcare providers and individuals to seek diagnostic tests, especially during peak flu seasons or outbreaks. In addition, governments often fund the development and distribution of advanced diagnostic tools, ensuring their availability in hospitals, clinics, and point-of-care settings. This increased focus on influenza control and prevention boosts demand for reliable and efficient diagnostics, fueling market growth.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global influenza diagnostics market is marked by the presence of established and emerging market players such as Thermo Fisher Scientific, Inc.; Becton, Dickinson and Company; F. Hoffmann-LA Roche AG; Hologic, Inc.; Abbott Laboratories, Inc.; Siemens Healthineers; Danaher Corporation; QuidelOrtho Corporation; BIOMÉRIEUX; and Meridian Bioscience Inc; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Scope | Details |
| Base Year Considered | 2023 |
| Historical Data | 2022 – 2023 |
| Forecast Period | 2024 - 2029 |
| Growth Rate | CAGR of 5-8% |
| Segment Scope | Product, Test Type, Specimen Type, End User |
| Regional Scope |
|
| Key Companies Mapped | Thermo Fisher Scientific, Inc.; Becton, Dickinson and Company; F. Hoffmann-LA Roche AG; Hologic, Inc.; Abbott Laboratories, Inc.; Siemens Healthineers; Danaher Corporation; QuidelOrtho Corporation; BIOMÉRIEUX; and Meridian Bioscience Inc; among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Key Strategic Questions Addressed
-
What is the market size & forecast of the influenza diagnostics market?
-
What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the influenza diagnostics market?
-
What are the key trends defining the market?
-
What are the major factors impacting the market?
-
What are the opportunities prevailing in the market?
-
Which region has the highest share in the global market?
-
Which region is expected to witness the highest growth rate in the next 5 years?
-
Who are the major players operating in the market?
-
What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2023-2024)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Influenza Diagnostics Market Snapshot (2023-2029)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Increasing incidence of influenza
- Government initiatives and awareness campaigns
- Technological advancements in diagnostics
- Globally rising healthcare expenditure
- Growing demand for rapid disease diagnosis
- Rising geriatric population
- Restraints
- Variability in sensitivity and specificity
- Stringent regulatory requirements
- High cost of product development cost
- Opportunities
- Point-of-care testing (POCT)
- Growing demand in developing regions
- Advancements in omics technologies
- Key Market Trends
- Development of multiplex assays
- Focus on pandemic preparedness and surveillance
- Rapid diagnostic tests (RDTs) with improved sensitivity
- Unmet Market Needs
- Industry Speaks
- Regulatory Analysis
- Global Influenza Diagnostics Market Size & Forecast (2022-2029), By Product, USD Million
- Introduction
- Test Kit and Reagents
- Instruments
- Other Products
- Introduction
- Global Influenza Diagnostics Market Size & Forecast (2022-2029), By Test Type, USD Million
- Introduction
- Molecular Diagnostic Tests
- Polymerase Chain Reaction
- RT-PCR (Reverse Transcriptase-PCR)
- Real-Time PCR
- Others
- Isothermal Nucleic Acid Amplification Tests (INAATs)
- Transcription-Mediated Amplification-Based (TMA) Assay
- Loop-Mediated Isothermal Amplification-Based (LAMP) Assay
- Nucleic Acid Sequence-Based Amplification (NASBA)Tests
- Other Isothermal Nucleic Acid Amplification Tests
- Other Molecular Tests
- Polymerase Chain Reaction
- Traditional Diagnostic Tests
- Rapid Influenza Diagnostic Tests
- Viral Culture Tests
- Immunoassay Tests
- Serological Tests
- Global Influenza Diagnostics Market Size & Forecast (2022-2029), By Specimen Type, USD Million
- Introduction
- Nasopharyngeal Swab
- Throat Swab
- Blood/Body Fluids
- Others
- Global Influenza Diagnostics Market Size & Forecast (2022-2029), By End User, USD Million
- Introduction
- Hospitals and Clinics
- Diagnostic Laboratories
- Home Care Settings
- Public Health Laboratories
- Others
- Global Influenza Diagnostics Market Size & Forecast (2022-2029), By Region, USD Million
- Introduction
- North America Influenza Diagnostics Market Size & Forecast (2022-2029), By Country, USD Million
- US
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By Specimen Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Canada
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By Specimen Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- US
- Europe Influenza Diagnostics Market Size & Forecast (2022-2029), By Country, USD Million
- UK
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By Specimen Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Germany
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By Specimen Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- France
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By Specimen Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Italy
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By Specimen Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Spain
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By Specimen Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Europe
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By Specimen Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- UK
- North America Influenza Diagnostics Market Size & Forecast (2022-2029), By Country, USD Million
- Introduction
-
-
- Asia Pacific (APAC) Influenza Diagnostics Market Size & Forecast (2022-2029), By Country, USD Million
- China
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By Specimen Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Japan
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By Specimen Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- India
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By Specimen Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By Specimen Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- China
- Latin America (LATAM) Influenza Diagnostics Market Size & Forecast (2022-2029), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By Specimen Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Middle East & Africa (MEA) Influenza Diagnostics Market Size & Forecast (2022-2029), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By Specimen Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Asia Pacific (APAC) Influenza Diagnostics Market Size & Forecast (2022-2029), By Country, USD Million
-
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2023)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2024)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Thermo Fisher Scientific, Inc.
- Becton, Dickinson and Company
- Hoffmann-LA Roche AG
- Hologic, Inc.
- Abbott Laboratories, Inc.
- Siemens Healthineers
- Danaher Corporation
- QuidelOrtho Corporation
- BIOMÉRIEUX
- Meridian Bioscience Inc.
- Other Prominent Players
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Hospitals and Clinics, Diagnostic Laboratories, Public Health Laboratories, and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
